Literature DB >> 27764883

Epidemiology of Familial Aggregation of Venous Thromboembolism.

Bengt Zöller1, Xinjun Li1, Henrik Ohlsson1, Jianguang Ji1, Ashfaque A Memon1, Peter J Svensson2, Karolina Palmér1, Björn Dahlbäck3, Jan Sundquist1, Kristina Sundquist1.   

Abstract

Familial aggregation (clustering) of venous thromboembolism (VTE) is the clustering of VTE within a family. Though several genes, such as antithrombin, protein C, protein S, factor V, and prothrombin are associated with the familial clustering of VTE, these loci only partially explain the familial aggregation of VTE. The epidemiology of the familial aggregation of VTE exhibits typical characteristics of complex traits. The family history of VTE in first-degree relatives is associated with a two to three times increased familial relative risk (FRR). The FRR of VTE is higher in younger individuals, increases with a number of affected relatives, decreases as the familial relationship becomes more distant, increases with severity (unprovoked), and exhibits slightly stronger male transmission (Carter effect). High FRR is observed in individuals with two or more affected siblings (FRR > 50). Because familial aggregation represents the sum of shared family environmental and genetic factors, one should not assume that evidence of familial aggregation implies genetic effects. However, studies in twins, extended families, adoptees, and spouses indicate a weak involvement of shared environmental factors to the familial aggregation of VTE. Moreover, familial aggregation of VTE fulfills the Hill's criteria for causation. In conclusion, familial aggregation of VTE signals a clinically relevant inherent predisposition for VTE. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27764883     DOI: 10.1055/s-0036-1593543

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Authors:  Abrar Ahmad; Ashfaque A Memon; Jan Sundquist; Peter J Svensson; Bengt Zöller; Kristina Sundquist
Journal:  Gene       Date:  2018-01-09       Impact factor: 3.688

2.  Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.

Authors:  Caroline Sindet-Pedersen; Louise Bruun Oestergaard; Anna Gundlund; Emil Loldrup Fosbøl; Kristian Aasbjerg; Jannik Langtved Pallisgaard; Gunnar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

3.  Concurrent pulmonary embolism in female monozygotic twins affected by Dercum's disease.

Authors:  Roberta Eufrasia Ledda; Joanna Raikes; Paola Crivelli; Immo Weichert
Journal:  Oxf Med Case Reports       Date:  2019-01-24

4.  Postoperative Joint Replacement Complications in Swedish Patients With a Family History of Venous Thromboembolism.

Authors:  Bengt Zöller; Peter J Svensson; Jan Sundquist; Kristina Sundquist; MirNabi Pirouzifard
Journal:  JAMA Netw Open       Date:  2018-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.